DAPK1 and Alzheimer disease: Notably, we observed that miR-143-3p significantly suppressed tau phosphorylation at Thr231, Ser262, and Ser396 and promoted neurite outgrowth and microtubule polymerization by inhibiting DAPK1, and these findings provide a potential therapeutic strategy against tau-related pathology in AD.